Background An increasing incidence of adenocarcinoma, a modified surgical strategy and
the increasing use of multimodal therapeutic protocols have had a major impact on the …

Esophageal cancer is a virulent malignancy associated with a 5-year overall survival of
approximately 5%. Treatment remains controversial—despite the results of prospective …

Abstract Esophageal Carcinoma: Surgical and Multimodal Therapy The prognosis of
surgically resected esophageal cancer has markedly improved during the past decades. In …

Surgery for esophageal cancer remains a cornerstone for early stage disease. The treatment
of more advanced locoregional disease is quite controversial. Efforts to improve survival in …

Esophageal cancer is a male-dominant aggressive malignancy and a leading cause of
cancer-related mortality worldwide. Squamous cell carcinoma and adenocarcinoma are the …

The terminology used to describe esophagectomy for carcinoma can be confusing, even for
specialists in gastrointestinal disease. As a result, specific terms are often used out of their …

Esophageal cancer is an aggressive disease with an overall poor prognosis.
Esophagectomy remains a key therapeutic option in treating patients who have this disease …

BACKGROUND: The aim of our study was the analysis of long-term developments in the
surgical therapy for esophageal carcinoma at our hospital over a period of 20 years with a …

Because of the perceived high risk of esophagectomy and the assumed poor long-term
results, the role of surgical resection as the mainstay of treatment for localized esophageal …

Prospective study, included 117 patients with esophageal cancer, all received resection of
the esophagus through laparatomy and and right-side thoracotomy without neoadjuvant …